.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Clinicians often face uncertainty when managing mild respiratory failure related to COVID-19. While the original COVID-HIGH trial showed no statistical significance, researchers recently performed a Bayesian reanalysis. This specific study evaluates high-flow nasal therapy COVID-19 versus conventional oxygen therapy (COT). The results suggest a high probability of benefit for patients receiving HFNT.
Specifically, the primary outcome focused on the escalation of respiratory support within 28 days. In the HFNT group, 23.6% of patients required escalation, compared to 30.2% in the COT group. Although the initial frequentist p-value was 0.14, the Bayesian model showed a high probability of benefit. Furthermore, the posterior probability of a positive outcome ranged between 70% and 94% across various models. The proportion of patients facing potential harm remained consistently low at less than 6%.
In addition, clinical recovery at day 14 was significantly improved in the HFNT group. Consequently, 61.5% of the HFNT group recovered compared to 53.3% of the COT group. This leads to a posterior probability of clinical benefit between 61% and 73%. Moreover, the Bayesian approach provides a more intuitive quantification of uncertainty. Therefore, these findings suggest that high-flow nasal therapy COVID-19 likely reduces treatment escalation. Doctors should consider these probabilities when determining the best course for mild hypoxaemia.
According to the Bayesian reanalysis, high-flow nasal therapy COVID-19 has a 70% to 94% probability of reducing the need for escalated respiratory support compared to conventional oxygen therapy.
The HFNT group showed a recovery rate of 61.5% at day 14, while the COT group showed 53.3%. This suggests a significant probability of clinical benefit for those using HFNT.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Crimi C et al. High-flow nasal therapy vs conventional oxygen therapy in mild COVID-19 hypoxaemia: a Bayesian reanalysis of the COVID-HIGH Trial. J Anesth Analg Crit Care. 2026 Feb 21. doi: 10.1186/s44158-026-00361-3. PMID: 41723547.
Crimi C, Noto A, Madotto F, et al. High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial. Thorax. 2023;78(4):354-361. doi: 10.1136/thoraxjnl-2022-218806.
Perkins GD, Ji C, Connolly BA, et al. Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial. JAMA. 2022;327(6):546–558. doi: 10.1001/jama.2022.0028.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A Bayesian reanalysis of the COVID-HIGH trial suggests HFNT likely reduces respiratory support escalation and improves recovery in mild COVID-19 cases....
8 months ago
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today
This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
